RhumbLine Advisers’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $14.5M | Sell |
|
|||||
|
2025
Q2 | $14.6M | Buy |
|
|||||
|
2025
Q1 | $15.1M | Sell |
|
|||||
|
2024
Q4 | $11.5M | Buy |
|
|||||
|
2024
Q3 | $8.95M | Buy |
|
|||||
|
2024
Q2 | $3.83M | Buy |
|
|||||
|
2024
Q1 | $3.03M | Buy |
|
|||||
|
2023
Q4 | $3.3M | Buy |
|
|||||
|
2023
Q3 | $1.58M | Sell |
|
|||||
|
2023
Q2 | $4.71M | Buy |
|
|||||
|
2023
Q1 | $2.7M | Buy |
|
|||||
|
2022
Q4 | $2.03M | Buy |
|
|||||
|
2022
Q3 | $962K | Buy |
|
|||||
|
2022
Q2 | $644K | Buy |
|
|||||
|
2022
Q1 | $1.26M | Buy |
|
|||||
|
2021
Q4 | $2.5M | Sell |
|
|||||
|
2021
Q3 | $4.42M | Buy |
|
|||||
|
2021
Q2 | $5.07M | Sell |
|
|||||
|
2021
Q1 | $6.94M | Sell |
|
|||||
|
2020
Q4 | $7.68M | Buy |
|
|||||
|
2020
Q3 | $3.51M | Sell |
|
|||||
|
2020
Q2 | $2.89M | Buy |
|
|||||
|
2020
Q1 | $1.17M | Buy |
|
|||||
|
2019
Q4 | $1.13M | Buy |
|
|||||
|
2019
Q3 | $537K | Buy |
|
|||||
|
2019
Q2 | $811K | Buy |
|
|||||
|
2019
Q1 | $625K | Sell |
|
|||||
|
2018
Q4 | $323K | Buy |
|
|||||
|
2018
Q3 | $291K | Sell |
|
|||||
|
2018
Q2 | $718K | Buy |
|
|||||
|
2018
Q1 | $655K | Buy |
|
|||||
|
2017
Q4 | $366K | Sell |
|
|||||
|
2017
Q3 | $632K | Buy |
|
|||||
|
2017
Q2 | $529K | Buy |
|
|||||
|
2017
Q1 | $489K | Buy |
|
|||||
|
2016
Q4 | $189K | Buy |
|
|||||
|
2016
Q3 | $292K | Buy |
|
|||||
|
2016
Q2 | $228K | Buy |
|
|||||
|
2016
Q1 | $293K | Buy |
|
|||||
|
2015
Q4 | $410K | Buy |
|
|||||
|
2015
Q3 | $323K | Sell |
|
|||||
|
2015
Q2 | $539K | Buy |
|
|||||
|
2015
Q1 | $413K | Buy |
|
|||||
|
2014
Q4 | $324K | Buy |
|
|||||
|
2014
Q3 | $202K | Buy |
|
|||||
|
2014
Q2 | $176K | Buy |
|
|||||
|
2014
Q1 | $73K | Sell |
|
|||||
|
2013
Q4 | $44K | Sell |
|
|||||
|
2013
Q3 | $59K | Buy |
|
|||||
|
2013
Q2 | $71K | Buy |
|